Quanterix' Simoa technology is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, this game-changing technology enables the development of methods providing much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.
Simoa Assays By The Numbers
Oncology Biomarker Assays
Inflammatory Biomarker Assays
Cardiology Biomarker Assays
Neurology Biomarker Assays
Watch our one minute video
Quanterix' proprietary Simoa™ technology is based on the isolation of individual immunocomplexes on paramagnetic beads using standard ELISA reagents.
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
Tauopathies are a group of disorders in which the cytosolic protein tau aggregates and accumulates…
Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines have been…
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated…
The results from these 2 independent cohort studies suggest that serum NFL is a highly sensitive…